TY - JOUR AU - Fenerty PY - 2018 DA - 2018// TI - Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition JO - J ImmunoTher Cancer VL - 6 UR - https://doi.org/10.1186/s40425-018-0445-4 DO - 10.1186/s40425-018-0445-4 ID - Fenerty2018 ER -